The needle stays hidden during injection and a sensor can detect placement on skin. It also includes 3 difference injection speeds, a progress bar and a speaker. Amgen announced the availability of ...

Whether starting or maintaining treatment, the Embark App has multiple features that can help patients on ENBREL throughout their treatment experience. As the healthcare industry continues to evolve ...

Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein, a marker of inflammation, in ...

May 23, 2005 — The European Commission has approved a 50-mg/mL formulation of etanercept injection for the treatment of rheumatoid arthritis, and the U.K.'s Medicine and Healthcare Products Regulatory ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

Amgen and Pfizer Announce Results From the Largest Completed Clinical Trial of a Biologic Therapy in Adults with Moderately Active RA THOUSAND OAKS, Calif. and NEW YORK, Nov. 5, 2011 /PRNewswire/ -- ...

Reports of success in treating Alzheimer’s disease using injections of the arthritis drug Enbrel have sparked hope among Alzheimer’s patients and their families -- and some concern among physicians. A ...

Amgen (NASDAQ:AMGN) today issued the following statement: Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel® (etanercept). This patent is owned by Hoffman-La Roche Inc.

The new lawsuit argues that the board’s action conflicted with federal patent laws by not allowing the company to charge as much as it wants.

Americans with psoriasis and rheumatoid arthritis will have to wait much longer for low-priced copycat versions of their weekly Enbrel injections. Amgen (NASDAQ: AMGN) won an appeals court ruling on ...

The competing rheumatoid arthritis drugs of Immunex Corp. and Johnson & Johnson may offer effective new approaches to easing the chronic skin flares of psoriasis, new research shows. A study presented ...

NEW YORK (Reuters Health) - A new study suggests that injections of steroids or arthritis drugs in the spine may not provide much extra relief for people with chronic back and leg pain due to nerve ...